Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Akanda Corp - SIC # 2833 - MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS
Ticker
Exchange
SIC #
Website
Latest Ticker
AKAN
Nasdaq
2833
https://akandacorp.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Akanda Corp
Akanda Announces No Equity Financing Until Further Notice
- Apr 15th, 2024 1:30 pm
Akanda Announces Plans to Enter Blockchain and AI Technology Sector
- Apr 12th, 2024 3:00 pm
Akanda Looks to Commercialize and Capitalize on Germany's Legalization of Cannabis, Opening Path to $3BN Market
- Apr 12th, 2024 12:00 pm
Akanda Corp. Announces Plan to Integrate Technology Solutions to Capture UK Market
- Apr 11th, 2024 3:00 pm
Akanda Corp. Announces Closing of the Sale of RPK
- Apr 11th, 2024 12:00 pm
Akanda Corp. Announces Canmart's Plans for Facebook and Instagram Social Shopping Technology Integration
- Mar 28th, 2024 2:00 pm
Akanda Corp. Announces Strategic Plan to Evaluate and Enter Bitcoin, Blockchain, AI Segments of the Cannabis Market
- Mar 28th, 2024 12:00 pm
Akanda Corp. Announces Closing of Underwritten Public Offering
- Mar 27th, 2024 9:30 pm
Univest Securities, LLC Announces Closing of $5 Million Underwritten Public Offering for its Client Akanda Corp. (NASDAQ: AKAN)
- Mar 27th, 2024 8:45 pm
Akanda Corp. Announces Pricing of Underwritten Public Offering
- Mar 25th, 2024 12:30 pm
RETRANSMISSION: Akanda Corp. Signs Share Purchase and Escrow Agreements for the Sale of Portuguese Assets to Somai Pharmaceuticals
- Mar 1st, 2024 1:30 pm
Akanda Corp. Signs Share Purchase and Escrow Agreements for the Sale of Portuguese Assets to Somai Pharmaceuticals
- Feb 29th, 2024 10:00 pm
Akanda Corp. Provides Further Update on Annual Meeting of its Shareholders
- Feb 21st, 2024 1:00 am
Akanda Corp. Provides Update on Annual Meeting of its Shareholders
- Feb 20th, 2024 1:30 pm
Akanda Corp. Discusses Positive Trends in UK Cannabis Market
- Feb 13th, 2024 1:00 pm
Akanda Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Feb 2nd, 2024 10:30 pm
Akanda Corp. Provides Update on Scheduling Policy in US Aims to Be Among First International Movers in US Pending Approval
- Feb 2nd, 2024 5:17 pm
Akanda Corp. Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- Feb 2nd, 2024 2:00 pm
Akanda Corp. Entered into Non-Binding Letter of Intent for Sale of RPK
- Feb 1st, 2024 1:30 pm
Akanda Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
- Jan 4th, 2024 9:01 pm
Scroll